Martha Sensel
About Martha Sensel
Martha Sensel serves as the Senior Director of Regulatory Writing at Kite Pharma, bringing extensive expertise in oncology and regulatory environments. She has a strong academic background with degrees from prestigious institutions and currently holds a leadership position at CERo Therapeutics, Inc.
Work at Kite Pharma
Martha Sensel has held multiple roles at Kite Pharma, contributing significantly to the regulatory writing team. She served as Senior Director of Regulatory Writing from 2018 to the present, where she has applied her extensive knowledge of the regulatory environment from pre-IND to post-market. Prior to this role, she was the Director of Regulatory Writing from 2016 to 2018. Additionally, she briefly worked as Interim Product Team Lead in 2021 for five months and as Executive Director from 2020 to 2021. Her experience at Kite Pharma has allowed her to develop a comprehensive understanding of regulatory requirements and effective communication strategies within the industry.
Education and Expertise
Martha Sensel has a robust academic background, having studied at several prestigious institutions. She earned her Bachelor of Science in Nutritional Biochemistry from The Ohio State University, followed by a PhD in the same field from Cornell University. She also completed postdoctoral research at Stony Brook University Health Sciences Center School of Medicine and at the University of California, Los Angeles, where she later obtained an MBA. Her educational achievements have equipped her with strong scientific expertise in oncology, particularly in hematologic malignancies and cell therapy.
Background
Martha Sensel has a diverse professional background that spans various roles in regulatory writing and leadership within the biopharmaceutical industry. She has been with Kite Pharma for several years, where she has transitioned through various positions, demonstrating her adaptability and expertise. In addition to her work at Kite, she is currently the Vice President of Portfolio and Public Affairs at CERo Therapeutics, Inc., a position she has held since 2021. Her career reflects a commitment to advancing therapeutic solutions in oncology and related fields.
Achievements
Martha Sensel has established herself as a leader in regulatory writing and scientific communication. Her advanced leadership training has enabled her to effectively build and manage scientific writing teams. She possesses a thorough understanding of global regulatory requirements related to clinical development, which has been instrumental in her roles at Kite Pharma and CERo Therapeutics. Her expertise spans various therapeutic areas, including oncology/hematology, biologic therapies for cancer, rheumatology, gastrointestinal disease, and neuropsychiatry.